A Case of an Elderly Frail Patient with Unresectable Colorectal Cancer Controlled by Trifluridine/Tipiracil with Bev-A cizumab Therapy as a First-Line Treatment

Ryu Matsumoto, Shinichiro Mori, Hiroko Toda, Yoshiaki Kita, Takaaki Arigami, Ken Sasaki, Hiroshi Kurahara, Kosei Maemura, Shoji Natsugoe

Research output: Contribution to journalArticlepeer-review

Abstract

Although the effectiveness of trifluridine/tipiracil (TFTD) with bevacizumab for unresectable colorectal cancer that was refractory to previous standard chemotherapy was reported, its effectiveness as a first-line treatment, especially for elderly frail patients, is unclear. An 85-year-old woman complaining of anorexia was diagnosed with unresectable sigmoid colon cancer with multiple metastases. Her general status was very poor, and her performance status (PS) was 4. We first performed laparoscopic transverse colostomy. As her general status gradually improved, we administered TFTD with bevacizumab as a first-line treatment based on the patient's strong request for chemotherapy The patient underwent this regimen in the outpatient clinic for 9 months (9 courses). Although the size of the liver metastases increased, lung metastases and abdominal disseminations were under control and her PS became 0. She has been taking mFOLFOX6 with bevacizumab (80%) as a second-line treatment. TFTD with bevacizumab treatment was safe and efficacious as a first-line treatment for a frail elderly patient with unresectable colorectal cancer.

Original languageEnglish
Pages (from-to)223-225
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume48
Issue number2
Publication statusPublished - 02-2021

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint

Dive into the research topics of 'A Case of an Elderly Frail Patient with Unresectable Colorectal Cancer Controlled by Trifluridine/Tipiracil with Bev-A cizumab Therapy as a First-Line Treatment'. Together they form a unique fingerprint.

Cite this